Biochemical engineering approaches to the challenges of producing pure plasmid DNA

Trends in Biotechnology

Volumn 18, Issue 7, 2000, Pages 296-305

  Levy, M Susana ^a   O'Kennedy, Ronan D ^a   Ayazi Shamlou, Parviz ^a   Dunnill, Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID DNA;

CELL SUSPENSION; CHEMICAL ENGINEERING; CONTROLLED STUDY; GENE THERAPY; HYDRODYNAMICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHEAR RATE; VACCINE PRODUCTION;

BIOTECHNOLOGY; DNA, RECOMBINANT; GENETIC ENGINEERING; PLASMIDS;

EID: 0034237305     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(00)01446-3     Document Type: Review

References (70)

1. Liljeqvist S., Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery and nucleic acid vaccines J. Biotechnol. 73:1999;1-33.
2. Friedman T. The road toward human gene therapy - a 25-year perspective. Ann. Med. 29:1997;575-577.
3. Robinson, H.L. et al. (1997) The scientific future of DNA for immunization. Academy Colloquia Report The American Society for Microbiology, Washington, DC, USA.
4. Mountain A. Gene therapy: the first decade Trends Biotechnol. 18:2000;119-128.
5. Cohen A.D. et al. Modulating the immune response to genetic immunization. FASEB J. 12:1998;1611-1626.
6. Newgard C.B. Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes Biotechnology. 10:1992;1112-1120.
7. Yarmush M.L., Berthiaume F. Metabolic engineering and human disease. Nat. Biotechnol. 15:1997;525-528.
8. Westphal E.M. et al. A system for shuttling 200-kb BAC/PAC clones into human cells. stable extrachromosomal persistence and long-term ectopic gene activation Hum. Gene Ther. 9:1998;1863-1873.
9. Willard H.F. Human artificial chromosomes coming into focus. Nat. Biotechnol. 16:1998;415-416.
10. Birnboim H.C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1979;1513-1523.
11. Thatcher, D.R. et al. (1997) Method of plasmid DNA production and purification. International Patent Application WO 97/29190.
12. Nabel G.J. et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans Proc. Natl. Acad. Sci. U. S. A. 90:1993;11307-11311.
13. Schleef M. Issues for large-scale plasmid DNA manufacturing. Rehm H.J., Reed G. Biotechnology: a Multi-Volume Comprehensive Treatise. Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes (Vol. 5a). 1999;443-470 Wiley-VCH.
14. Horn N.A. et al. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials Hum. Gene Ther. 6:1995;565-573.
15. Lahijani R. et al. Quantitation of host cell DNA contaminate in pharmaceutical-grade plasmid DNA using competitive polymerase chain reaction and enzyme-linked immunosorbent assay. Hum. Gene Ther. 9:1998;1173-1180.
16. Noites I.S. et al. Rapid quantitation and monitoring of plasmid DNA using an ultrasensitive DNA-binding dye. Biotechnol. Bioeng. 66:1999;195-201.
17. Levy M.S. et al. Quantitation of supercoiled circular content in plasmid DNA solutions using a fluorescence-based method. Nucleic Acids Res. 2000;. (in press).
18. Charm S.E., Wong B.L. Shear effects on enzymes. Enzyme Microb. Technol. 3:1981;111-118.
19. Thomas C.R., Dunnill P. Action of shear on enzymes. studies with catalase and urease Biotechnol. Bioeng. 21:1979;2279-2302.
20. Virkar P.D. et al. Studies of the effects of shear on globular proteins: extension to high shear fields and to pumps Biotechnol. Bioeng. 23:1981;425-429.
21. Smith E.L. et al. Principles of Biochemistry: General Aspects. 1978;McGraw-Hill.
22. Ayazi Shamlou P., Titchener-Hooker N. Turbulent aggregation and breakup of particles in stirred vessels. Ayazi Shamlou P. Processing of Solid-Liquid Suspensions. 1993;1-24 Butterworth Heinemann.
23. Ledley F.D. Pharmaceutical approach to somatic gene therapy. Pharm. Res. 13:1996;1595-1614.
24. Levy M.S. et al. Effect of shear on plasmid DNA in solution. Bioprocess Eng. 20:1999;7-13.
25. Hoare M.et al. Interfacial damage of proteins during intensive mixing in fermentation and downstream processing. Van den Tweel W.J. et al. Proceedings of Stability and Stabilization of Enzymes. 1993;21-27 Elsevier Science.
26. Ciccolini L.A.S. et al. Time course of SDS-alkaline lysis of recombinant bacterial cells for plasmid release. Biotechnol. Bioeng. 60:1998;768-770.
27. Ciccolini L.A.S. et al. Rheological properties of chromosomal and plasmid DNA during alkaline lysis reaction. Bioprocess Eng. 21:1999;231-237.
28. Carlson A. et al. Mechanical disruption of Escherichia coli for plasmid recovery. Biotechnol. Bioeng. 48:1995;303-315.
29. Lee, A.L. and Sagar, S. (1996) A method for large scale plasmid purification. US Patent Application PCT/US95/08749.
30. Wan, N.C. et al. (1997) Method for lysing cells. International Patent Application WO 97/23601.
31. Levy M.S. et al. The effects of material properties and fluid flow intensity on plasmid DNA recovery during cell lysis. Chem. Eng. Sci. 54:1999;3171-3178.
32. Bell D.J., Dunnill P. The influence of precipitation reactor configuration on the centrifugal recovery of isoelectric soya protein precipitate. Biotechnol. Bioeng. 24:1982;2319-2336.
33. Maybury J. et al. The performance of a scaled down industrial disc stack centrifuge with a reduced feed material requirement. Bioprocess Eng. 18:1998;231-237.
34. Theodossiou I. et al. The processing of a plasmid-based gene from Escherichia coli. Primary recovery by filtration. Bioprocess Eng. 16:1997;175-183.
35. Theodossiou I. et al. Methods of enhancing the recovery of plasmid genes from neutralised cell lysate. Bioprocess Eng. 20:1999;147-156.
36. Hayashizaki, Y. (1997) Method for the purification of DNA. European Patent Application EP/0814156A2.
37. Horn, N. et al. (1996) Process for reducing RNA concentration in a mixture of biological material using diatomaceous earth. International Patent Application WO 96/21729.
38. Bussey, L. et al. (1998) Methods for purifying nucleic acids. International Patent Application WO 98/05673.
39. Levy M.S. et al. Removal of contaminant nucleic acids by nitrocellulose filtration during pharmaceutical plasmid DNA processing. J. Biotechnol. 76:2000;197-205.
40. Marquet, M. et al. (1995) Production of pharmaceutical-grade plasmid DNA. International Patent Application WO 95/21250.
41. Lis J.T. Fractionation of DNA fragments by polyethylene glycol induced precipitation. Methods Enzymol. 65:1980;347-353.
42. Lis J.T., Schleif R. Size fractionation of double stranded DNA by precipitation with polyethylene glycol. Nucleic Acids Res. 2:1975;383-389.
43. Chen, Z. and Ruffner, D. (1998) Compositions and methods for rapid isolation of plasmid DNA. International Patent WO 98/16653.
44. Olmsted M.C., Hagerman P.J. Excess counterion accumulation around branched nucleic acids. J. Mol. Biol. 243:1994;919-929.
45. McNeilly, D. (1999) Method for purifying plasmid DNA and plasmid DNA substantially free of genomic DNA. International Patent WO 99/29832.
46. Murphy J.C. et al. Purification of plasmid DNA using selective precipitation by compaction agents. Nat. Biotechnol. 17:1999;822-823.
47. Wils P. et al. Efficient purification of plasmid DNA for gene transfer using triple-helix affinity chromatography. Gene Ther. 4:1997;323-330.
48. Prazeres D.M.F. et al. Preparative purification of supercoiled plasmid DNA using anion exchange chromatography. J. Chromatogr. A. 806:1998;31-45.
49. Ljunglof A. et al. Direct visualisation of plasmid DNA in individual chromatography adsorbent particles by confocal scanning laser microscopy. J. Chromatogr. A. 844:1999;129-135.
50. Horn, N. et al. (1998) Purification of plasmid DNA during column chromatography. US Patent US/5707812.
51. Durland R.H., Eastman E.M. Manufacturing and quality control of plasmid-based gene expression systems. Adv. Drug Del. Rev. 30:1998;33-48.
52. McCabe, D.E. (1999) Gas driven gene delivery instrument. US Patent US/5865796.
53. Chonn A., Cullis P.R. Recent advances in liposomal drug-delivery systems. Curr. Opin. Biotechnol. 6:1995;698-708.
54. Yanez R.J., Porter A.C.G. Therapeutic gene targeting. Gene Ther. 5:1998;149-159.
55. Crook K. et al. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Hum. Gene Ther. 3:1996;834-839.
56. Tsai J.T. et al. Characterisation of plasmid DNA conjugates as a basis for their processing. Bioprocess Eng. 21:1999;279-286.
57. Larocca D. et al. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum. Gene Ther. 9:1998;2398-2399.
58. Perham, R.N. et al. (1997) Engineered bacteriophages and the vaccines containing them. European Patent EP/0552267 B1.
59. Tservistas M. Supercritical fluids for dry powder formulation of plasmid DNA. Hofman M. Proceedings of Ninth European Congress of Biotechnology (ECB9). 1999;Branche Belge de la Societe de Chimie Industrielle.
60. Hanak, J.A.J. et al. (1999) Purification of cellular components that are substantially RNA free. International Patent WO/9953018.
61. Sherratt, D.J. et al. (1999) Plasmid stabilization. US Patent US/5972708.
62. Reinikainen P. et al. Escherichia coli plasmid production in a fermenter. Biotechnol. Bioeng. 33:1989;386-393.
63. Hecker M. et al. Replication of pBR322 DNA in stringent and relaxed strains of Escherichia coli. Mol. Gen. Genet. 190:1983;355-357.
64. Clewell D.B. Nature of ColE1-plasmid replication in Escherichia coli in the presence of chloroamphenicol. J. Bacteriol. 110:1972;667-676.
65. Lahijani R. et al. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum. Gene Ther. 7:1996;1971-1980.
66. Leipold R.J. et al. Mathematical model for temperature-sensitive plasmid replication. Plasmid. 32:1994;131-167.
67. Middaugh C.R. et al. Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87:1998;131-146.
68. O'Kennedy R.D. et al. Effects of growth medium selection on plasmid DNA production and initial processing step. J. Biotechnol. 76:2000;175-183.
69. Mizushima T. et al. Increase in negative supercoiling of plasmid DNA in Escherichia coli exposed to cold shock. Mol. Microbiol. 23:1997;381-386.
70. Lowrie D.B. et al. Therapy of tuberculosis in mice by DNA vaccination. Nature. 400:1999;269-271.